Gender
Visit number vs Serum creatinine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline Visit | 130 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 39 | 169 |
Month-6 Follow-up Visit | 131 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 38 | 169 |
Month-12 Follow-up Visit | - | - | - | - | - | - | - | - |
Treatment arm vs Serum creatinine
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 130 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 39 | 169 |
Conservative Medical Therapy (CMT) | 34 | 1.0 | ± 0.3 | 0.9 | 0.5 | 1.7 | 10 | 44 |
CMT + Sham CPAP | 33 | 0.9 | ± 0.2 | 0.8 | 0.5 | 1.5 | 9 | 42 |
CMT + Active CPAP | 32 | 1.0 | ± 0.2 | 1.0 | 0.5 | 1.6 | 10 | 42 |
CMT + Active CPAP + Motivational Enhancement | 31 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.2 | 10 | 41 |
Treatment arm vs Serum creatinine
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 131 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 38 | 169 |
Conservative Medical Therapy (CMT) | 35 | 1.0 | ± 0.3 | 0.9 | 0.5 | 1.8 | 9 | 44 |
CMT + Sham CPAP | 33 | 0.9 | ± 0.2 | 0.8 | 0.5 | 1.6 | 9 | 42 |
CMT + Active CPAP | 32 | 1.0 | ± 0.2 | 0.9 | 0.6 | 1.5 | 10 | 42 |
CMT + Active CPAP + Motivational Enhancement | 31 | 0.9 | ± 0.2 | 0.9 | 0.6 | 1.2 | 10 | 41 |
Age at visit vs Serum creatinine
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 130 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 39 | 169 |
46.0 to 59.0 years | 28 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.6 | 15 | 43 |
59.0 to 66.0 years | 31 | 0.9 | ± 0.3 | 0.9 | 0.5 | 1.4 | 11 | 42 |
66.0 to 69.0 years | 38 | 1.0 | ± 0.2 | 0.9 | 0.5 | 1.7 | 4 | 42 |
70.0 to 76.0 years | 33 | 1.0 | ± 0.3 | 0.9 | 0.6 | 1.7 | 9 | 42 |
Age at visit vs Serum creatinine
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 131 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 38 | 169 |
46.0 to 60.0 years | 27 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.5 | 16 | 43 |
60.0 to 66.0 years | 32 | 0.9 | ± 0.2 | 0.9 | 0.6 | 1.4 | 10 | 42 |
66.0 to 70.0 years | 38 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.4 | 4 | 42 |
70.0 to 77.0 years | 34 | 1.0 | ± 0.3 | 0.9 | 0.6 | 1.8 | 8 | 42 |
Gender vs Serum creatinine
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 130 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 39 | 169 |
Male | 90 | 1.0 | ± 0.2 | 1.0 | 0.7 | 1.7 | 20 | 110 |
Female | 40 | 0.8 | ± 0.2 | 0.8 | 0.5 | 1.4 | 19 | 59 |
Gender vs Serum creatinine
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 131 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 38 | 169 |
Male | 91 | 1.0 | ± 0.2 | 1.0 | 0.7 | 1.8 | 19 | 110 |
Female | 40 | 0.8 | ± 0.2 | 0.8 | 0.5 | 1.2 | 19 | 59 |
Race vs Serum creatinine
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 129 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 39 | 168 |
White | 120 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.7 | 32 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 6 | 1.1 | ± 0.2 | 1.1 | 0.9 | 1.4 | 5 | 11 |
Asian | 3 | 0.9 | ± 0.2 | 1.0 | 0.7 | 1.1 | 1 | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |
Race vs Serum creatinine
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 130 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 38 | 168 |
White | 121 | 0.9 | ± 0.2 | 0.9 | 0.5 | 1.8 | 31 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 6 | 1.1 | ± 0.1 | 1.2 | 0.8 | 1.2 | 5 | 11 |
Asian | 3 | 0.9 | ± 0.2 | 1.0 | 0.7 | 1.1 | 1 | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |